Quality of life in thalassemia major: Reliability and validity of the Persian version of the SF-36 questionnaire

Journal of Postgraduate Medicine

Volumn 54, Issue 4, 2008, Pages 273-275

  Jafari, H ^a   Lahsaeizadeh, S ^a   Jafari, P ^b   Karimi, M ^a  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Iran; Quality of life; SF 36; Thalassemia

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; EMOTIONALITY; FEMALE; HEALTH SURVEY; HUMAN; IRAN; MAJOR CLINICAL STUDY; MALE; PREVALENCE; QUALITY OF LIFE; QUESTIONNAIRE; THALASSEMIA MAJOR;

ADOLESCENT; ADULT; BETA-THALASSEMIA; CROSS-CULTURAL COMPARISON; EDUCATIONAL STATUS; EMPLOYMENT; FEMALE; HEALTH SURVEYS; HUMANS; IRAN; MALE; POPULATION SURVEILLANCE; PSYCHOMETRICS; QUALITY OF LIFE; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; YOUNG ADULT;

EID: 55549118240     PISSN: 00223859     EISSN: None     Source Type: Journal    
DOI: 10.4103/0022-3859.41432     Document Type: Article

References (16)

1. Ismail A, Campbell MJ, Ibrahim HM, Jones GL. Health related quality of life in Malaysian children with thalassaemia. Health Qual Life Outcomes 2006;4:39.
2. Angastiniotis M, Modell B. Global epidemiology of hemoglobin disorders. Ann N Y Acad Sci 1998;850:251-69.
3. Weatherall D. The thalassemias: The role of molecular genetics in an evolving global health problem. Am J Hum Genet 2004;74:385-92.
4. Mikelli A, Tsiantis J. Brief report: Depressive symptoms and quality of life in adolescents with b-thalassemia. J Adolescence 2004;27:213-6.
5. Brittenham GM, Griffith PM, Nienhuis AW, McLaren CE, Young NS, Tucker EE, et al. Efficacy of deferoxamine in preventing complications of iron overload in patients with thalassemia major. N Engl J Med 1994;331:567-73.
6. Telfer P, Coen PG, Christou S, Hadjigavriel M, Kolnakou A, Pangalou E, et al. Survival of medically treated thalassemia patients in Cyprus: Trends and risk factors over the period 1980-2004. Haematologica 2006;91:1187-92.
7. Olivieri NF, Brittenham GM. Iron-chelating therapy and the treatment of Thalassemia. Blood 1997;89:739-761.
8. Pakbaz Z, Treadwell M, Yamashita R, Quirolo K, Foote D, Quill L, et al. Quality of life in patients with thalassemia intermedia compared to thalassemia major. Ann N Y Acad Sci 2005;1054:457-61.
9. Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36) I conceptual framework and item selection. Med Care 1992;30:473-83.
10. Khurana A, Katyal S, Marwaha RK. Psychosocial burden in thalassemia. Indian J Pediatr 2006;73:877-80.
11. Roy T, Chatterjee SC. The experiences of adolescents with thalassemia in West Bengal, India. Qual Health Res 2007;17:85-93.
12. Ware JE Jr, Gandek B. Overview of the SF-36 health survey and the international quality of life assessment project. J Clin Epidemiol 1998;51:903-12.
13. Montazeri A, Goshtasebi A, Vahdaninia M, Gandek B. The short form health survey: Translation and validation study of Iranian version. Qual Life Res 2005;14:875-82.
14. Motamed N, Ayatollahi AR, Zare N, Sadeghi-Hassanabadi A. Validity and reliability of the Persian translation of the SF-36 version 2 questionnaire. East Med Health J 2005;11:349-57.
15. Fukuhara S, Bito S, Green J, Hsiao A, Kurokawa K. Translation, adaptation, and validation of the SF-36 Health Survey for use in Japan. J Clin Epidemiol 1998;51:1037-44.
16. Sabbah I, Drouby N, Sabbah S, Retel-Rude N, Mercier M. Quality of Life in rural and urban populations in Lebanon using SF-36 Health Survey. Health Qual Life Outcomes 2003;1:30.